Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BCAL | TCBX |
|---|---|---|
| Price | $21.38 | $41.27 |
| Change today | ▼ 1.29% | ▼ 4.07% |
| Market cap | $687.38M | $687.35M |
| Return, 3 months | +5.0% | +3.8% |
| Return, year to date | +16.4% | +8.6% |
| Return, 1 year | +30.9% | +6.3% |
| P/E (TTM) | 11.6 | 10.3 |
| P/B | 1.2 | 1.0 |
| P/E percentile vs own 5y | 60th | 26th |
| Dividend yield | 1.40% | – |
| Revenue growth (YoY, latest qtr) | +1.4% | +30.5% |
| Net profit growth (YoY) | +1.4% | +31.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 33.4% | 29.6% |
| Return on equity | 10.6% | 11.9% |
| Analyst target vs. price | +14.6% | +19.5% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 46 | 32 |
| 30-day volatility | 14.3% | 22.5% |
| Max drawdown, 1 year | -13.5% | -16.1% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
